# Neuromodulation in Patients With Pulmonary Arterial Hypertension

> **NCT06802380** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **University of Oklahoma** · enrollment: 50 (estimated)

## Conditions studied

- Pulmonary Hypertension

## Interventions

- **DEVICE:** Low-level tragus stimulation
- **DEVICE:** Sham stimulation

## Key facts

- **NCT ID:** NCT06802380
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2026-11-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06802380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06802380, "Neuromodulation in Patients With Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06802380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*